Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Innovation Pharmaceuticals Doses First Cohort of Oral Brilacidin for Ulcerative Colitis

americanpharmaceuticalreviewJanuary 19, 2020

Tag: Innovation Pharmaceuticals , oral Brilacidin , ulcerative colitis

PharmaSources Customer Service